Automation and AI software for radiation oncology treatment planning
Radformation builds automation software for radiation oncology clinics, covering plan checks, dose calculation, AI contouring and billing QA. Its stack pairs a .NET/C#/WPF desktop core with clinical integrations into Eclipse, RayStation, ARIA, Elekta Unity and HL7. Accelerating, support- and sales-heavy hiring across Italy, Germany, Portugal, Belgium and Poland, plus distributor certification work, points to a push into European markets through channel partners.
Radformation is a privately held software company founded in 2016 and headquartered in New York, with 51–200 employees. It sells FDA-cleared tools to radiation oncology clinics, spanning automated plan checking, independent dose calculation, one-click 3D planning, AI-based contouring, ongoing treatment monitoring and billing code QA. Products include ClearCheck, ClearCalc, EZFluence, AutoContour, ChartCheck and QuickCode. The company runs its go-to-market on Salesforce, Salesforce CPQ, HubSpot and Gong, with NetSuite and Ramp supporting finance operations.
Radformation builds with C#, .NET, .NET Core, WPF, C++, Python, Java and JavaScript, backed by SQL Server, PostgreSQL and MongoDB, and integrates with Eclipse, RayStation, ARIA, Elekta Unity and HL7.
Radformation is hiring in the United States, Italy, Germany, Portugal, Belgium and Poland, with openings concentrated in support and sales alongside engineering and data roles.
Current work includes ChartCheck application development, model training for AutoContour, verification and validation testing, radiotherapy plan checking workflows, and a distributor certification and onboarding program.
Other companies in the same industry, closest in size
Radformation's technology stack, projects, and hiring signals are inferred from public hiring and company data — career pages, public listings, and company web presence — then clustered and de-duplicated. Figures are estimates that refresh over time. Read our full methodology →
This is not an official vendor or customer list. It is a technology-adoption signal inferred from public data, intended for B2B research.